Reaching the SDG targets on Health by 2030: ECDC Session at European Health Forum Gastein 2018

News story

Will we reach the United Nations Sustainable Development Goal (SDG) for health by 2030 and the targets set for HIV/AIDS, hepatitis and tuberculosis? ECDC’s session at the European Health Forum Gastein looks at the action required to end AIDS and TB, and to combat hepatitis.

As part of the overall theme of the European Health Forum Gastein (EHFG) 2018, “Health and Sustainable Development: Bold political choices for Agenda 2030”, ECDC’s session will explore the status in the EU with regard to HIV/AIDS, viral hepatitis and tuberculosis (TB), and whether Europe is on track to reach the Sustainable Development Goal for health. The session will highlight the remaining challenges and actions needed to end AIDS and TB, and eliminate viral hepatitis as a public health threat by 2030. ECDC Director, Dr. Andrea Ammon sets the agenda:

The Sustainable Development Goal for health is by no means an impossible feat for Europe, however the scale of the epidemics in the EU and EEA countries vary, as do their health systems. Overall, reaching and testing those at risk of infection is still a public health challenge across Europe, but if we want to interrupt existing transmission chains and prevent further infections, we need to strengthen local prevention and control practices.

Andrea at Gastein
ECDC Director Andrea Ammon at EHFG 2017 (© Framez)

ECDC Director Andrea Ammon will be moderating the session, which includes speakers Vinay P. Saldanha (UNAIDS Regional Director for Eastern Europe and Central Asia), Freek Spinnewijn (Director for FEANTSA, European Federation of National Organisations Working with the Homeless), Fanny Voitzwinkler (Head of EU Office, Global Health Advocates), Tuula Vasankari (Secretary General, FILHA, Finnish Lung Health Association), Nikos Dedes (European AIDS Treatment Group) and Ricardo Baptista Leite (Member of Parliament and permanent member of the Parliamentary Health Committee, Portugal).

The session will take place on Thursday, 4 October 2018, from 09:00 – 11:30 in Bad Hofgastein. Highlights from the session will be available on the ECDC tuberculosis and HIV/AIDS Twitter accounts @ECDC_TB and @ECDC_HIVAIDS, as well as from @ECDC_EU.

More about hepatitis

Hepatitis B and C epidemiology in selected population groups in the EU/EEA

The findings presented in this report will be part of the process of developing a European guidance for HBV and HCV testing and may provide support EU/EEA countries in the development of national guidelines and in the design and scale-up of testing interventions.

EU/EEA capacity for the surveillance of hepatitis B and C using molecular methods

In order to explore whether the current capacity for EU/EEA-wide molecular characterisation for surveillance of HBV and HCV is sufficient to be feasible and what gaps need to be addressed, a survey of EU/EEA Member States was conducted to assess their laboratory capacity and needs in relation to the molecular characterisation of hepatitis B and C.

Hepatitis B - Annual Epidemiological Report for 2016

In 2016, 30 EU/EEA Member States reported 29 307 cases of hepatitis B virus (HBV) infection, corresponding to a crude rate of 5.5 cases per 100 000 population.

Hepatitis C prevalence database

Prevalence data from sources such as population surveys can be a useful complement to case based surveillance data for hepatitis C. Case-based surveillance has limitations as most diagnosed cases are chronic in nature and detection of cases depends largely on testing practices. Prevalence data can therefore contribute towards a fuller understanding of the epidemiology of hepatitis C.

Hepatitis C - Annual Epidemiological Report for 2016

In 2016, 33 860 cases of hepatitis C were reported in 29 EU/EEA Member States, corresponding to a crude rate of 7.4 cases per 100 000 population.

World Hepatitis Day 2018

On the occasion of World Hepatitis Day, ECDC launched online prevalence database for hepatitis B and C which included data mainly based on peer-reviewed cross sectional studies from 2006 onwards.

More about HIV/AIDS

HIV/AIDS surveillance in Europe 2017 - 2016 data

This report, prepared jointly with the WHO Regional Office for Europe, presents data on HIV and AIDS for the whole European Region, including the EU and EEA countries. Analyses are provided for the EU and EEA region, and also by geographical/epidemiological division of the WHO European Region.

HIV and AIDS - Annual Epidemiological Report for 2016

In 2016, 29 444 people were newly diagnosed with HIV in the 31 countries of the EU/EEA, which equals a rate of 5.7 cases per 100 000 population

Dublin Declaration monitoring - 2016 progress

Every second year, ECDC assesses and reports on the progress of the implementation of the Dublin Declaration through a series of thematic report and evidence briefs. Here you can find the 2016 progress reports.

Public health guidance on HIV and STI prevention among men who have sex with men

This guidance, based on a systematic review of the literature and expert opinion, suggests that there is good evidence to ensure that some key components are considered for inclusion in national and sub-national public health programmes in countries in Europe.

World AIDS Day 2017

One in 2 people living with HIV are diagnosed late in the course of their infection. So late, that two out of three people with AIDS in the EU/EEA receive their diagnosis within only three months of discovering they had HIV. For World AIDS Day 2017, ECDC highlighted the problem of late diagnosis and the need for diversifying HIV testing approaches.

More about tuberculosis

Press release: 4% annual decrease too slow to end TB by 2030 – call for Europe’s commitment to increase investment to end TB

A new report published today by the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe indicates that the number of new tuberculosis (TB) patients has been decreasing at an average rate of 4.3% per year in the WHO European Region over the last decade.

Tuberculosis surveillance and monitoring in Europe, 2018

The Annual TB Surveillance and Monitoring report presents the key figures and trends and provides an overview of the TB situation in the EU/EEA and the WHO European Region.

Tuberculosis situation in the EU/EEA, 2018 - 2016 data

Findings from the joint report Tuberculosis surveillance and monitoring in Europe by ECDC and WHO Regional Office for Europe

Tuberculosis - Annual Epidemiological Report for 2016

Thirty EU/EEA countries reported 58 994 TB cases, 11.4 cases per 100 000 population.

European Union Standards for Tuberculosis Care

ECDC and the European Respiratory Society (ERS) have developed the European Union Standards for Tuberculosis Care (ESTC).

Tuberculosis Action Plan for the WHO European Region 2016-2020 EU/EEA - 2016 data

Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016

World Tuberculosis Day - 2018

World Tuberculosis Day - marked each year on 24 March – is an occasion to raise awareness and advocate for efforts to eliminate TB.